Monumental Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$1.8M Sell
2,036
-298
-13% -$268K 0.67% 18
2024
Q2
$2.11M Sell
2,334
-367
-14% -$294K 0.92% 17
2024
Q1
$2.1M Sell
2,701
-102
-4% -$72.6K 1.12% 16
2023
Q4
$1.63M Sell
2,803
-108
-4% -$63K 0.97% 16
2023
Q3
$1.56M Buy
2,911
+99
+4% +$51K 1.04% 18
2023
Q2
$1.32M Sell
2,812
-591
-17% -$248K 0.89% 20
2023
Q1
$1.17M Buy
3,403
+182
+6% +$61.4K 0.84% 28
2022
Q4
$1.18M Buy
3,221
+2,589
+410% +$918K 0.95% 19
2022
Q3
$204K Buy
+632
New +$200K 0.19% 32
2022
Q2
Sell
-224
Closed -$64K 52
2022
Q1
$64K Buy
+224
New +$57.6K 0.05% 29
2021
Q3
Sell
-186
Closed -$43K 60
2021
Q2
$43K Sell
186
-3,408
-95% -$685K 0.04% 48
2021
Q1
$671K Buy
+3,594
New +$703K 0.64% 29

Other funds holding LLY

Monumental Financial Group's LLY Position: Q3 2024 in Review

Monumental Financial Group reduced its Eli Lilly (LLY) stake by 13% in Q3 2024, selling an estimated $268K and leaving 2,036 shares worth $1.8M. The position accounts for 0.67% of the portfolio, ranked #18.

Monumental Financial Group first reported a position in LLY in Q1 2021 and has held it in 12 quarters since. The position peaked at $2.11M in Q2 2024. 3,663 funds tracked by Wall St. Rank hold LLY as of Q3 2024.

  • Monumental Financial Group held 2,036 shares of Eli Lilly worth $1.8M as of Q3 2024.
  • Monumental Financial Group sold 298 Eli Lilly shares in Q3 2024, an estimated $268K.
  • Eli Lilly made up 0.67% of Monumental Financial Group's portfolio in Q3 2024, its #18 holding.
  • Monumental Financial Group first reported a position in Eli Lilly in Q1 2021 and has held it in 12 quarters since.
  • Monumental Financial Group's Eli Lilly position peaked at $2.11M in Q2 2024.
  • 3,663 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2024.

Based on Monumental Financial Group's 13F filing for Q3 2024, filed 21 Oct 2024.